Related Experiment Videos
Modulation of disease by superantigens
1Department of Microbiology and Cell-Science, University of Florida, Gainesville 32611, USA. btorres@micro.ifas.ufl.edu
Current Opinion in Immunology
|September 2, 1998
Summary
Bacterial and viral superantigens trigger immune-mediated diseases like multiple sclerosis by activating autoreactive T cells. These superantigens may also contribute to other autoimmune conditions, influencing disease progression.
Area of Science:
- Immunology
- Autoimmunity
- Molecular Biology
Background:
- Superantigens, potent immune activators, are increasingly implicated in autoimmune diseases.
- Evidence suggests a role for both bacterial and viral superantigens in disease pathogenesis.
Purpose of the Study:
- To investigate the role of superantigens in immune-mediated diseases, particularly multiple sclerosis.
- To explore the mechanisms by which superantigens influence T cell responses and disease progression.
Main Methods:
- Utilized an animal model for multiple sclerosis to study superantigen effects.
- Analyzed T cell receptor V beta family usage in response to superantigens.
- Examined the potential involvement of epitope spreading in disease exacerbation.
Main Results:
- Superantigens were shown to induce relapses in a multiple sclerosis animal model.
- Autoreactive T cells with restricted T cell receptor V beta usage were activated by superantigens.
- Superantigens, including those from mouse mammary tumor virus, were linked to disease progression in other autoimmune conditions like rheumatoid arthritis and psoriasis.
Conclusions:
- Superantigens are significant contributors to the development and progression of immune-mediated diseases.
- Superantigen activity, involving specific T cell responses and epitope spreading, is a key factor in autoimmune disease pathogenesis.
- Targeting superantigens may offer therapeutic strategies for autoimmune disorders.